Annual Report 2022

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2022 121 The United Laboratories International Holdings Limited Annual Report 2022 29. BORROWINGS 2022 2021 RMB’000 RMB’000 Bank loans 2,203,769 1,757,229 Discounted bills with recourse (Note 24) 251,378 18,353 Other loans – 55,536 2,455,147 1,831,118 Analysed as: Secured 251,378 300,773 Unsecured 2,203,769 1,530,345 2,455,147 1,831,118 The carrying amount of the bank loans are repayable: – Within one year 97,129 980,434 – Within a period of more than one year, but not exceeding two years 132,590 11,344 – Within a period of more than two years but not more than five years 963,199 209,868 1,192,918 1,201,646 The carrying amount of bank loans that contain a repayment on demand clause (shown under current liabilities) but repayable*: – Within one year 124,113 268,698 – Within a period of more than one year, but not exceeding two years 434,398 – – Within a period of more than two years but not more than five years 452,340 286,885 2,203,769 1,757,229 The carrying amount of the non-bank loans are repayable: – Within one year 251,378 73,889 2,455,147 1,831,118 Less: Amount due within one year shown under current liabilities (1,359,358) (1,609,906) Amount shown under non-current liabilities 1,095,789 221,212 * The amounts due are based on scheduled repayment dates set out in the loan agreements.